Plenary session
Main hall
Plenary session
BEST APPROACHES TO REGULATION OF MEDICINES IN A MULTIPOLAR WORLD
PART 2
Questions and topics for discussion:
- EAEU’s Strategy-2025: What is it and why? Results of the first years of the operation of the common pharmaceutical market and medicine registration procedure according to the EAEU guidelines
- Provisional procedure established for 2020-2023 by the national legislation of the EAEU member states for the circulation of medicines in terms of registration of medicines
- Inspections of pharmaceutical manufacturers as per the EAEU guidelines. Establishing uniform approaches
- Challenges Russian pharmaceutical enterprises face while entering the global markets
- Mutual recognition. International experience
MODERATORS
Alena Launik
Head of the Department of Pharmaceutical Inspection of the Main Department for Control of Medical Activities and Circulation of Medicines of the Ministry of Health of the Republic of Belarus
Vladislav Shestakov
Director of the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of the Russian Federation
SPEAKERS
Dmitry Rozhdestvensky
Olga Zhuravleva
Deputy Director of the Unitary Enterprise «Center for Expertise and Testing in Healthcare» of the Ministry of Health of the Republic of Belarus
Anar Amirova
Mirbek Nyshanbaev
Madina Sottaeva
Head of Pharmaceutical Manufacturing Production Inspection Department of the Federal State Institution «SID and GP» under the Ministry of Industry and Trade of the Russian Federation
Teinji Zin
Senior GMP Inspector, Food and Drug Administration, Myanmar
Sladjana Marsenich
